The global cancer biomarkers market is projected to grow from $27.6 billion in 2025 to $58 billion by 2032, at a CAGR of 11.2%. Growth is fueled by rising cancer cases, advances in genetic and epigenetic biomarker technologies, and increasing demand for personalized oncology and non-invasive diagnostics like liquid biopsies. The Asia Pacific region shows high potential due to increased healthcare spending. Innovations such as AI analytics and omics technologies are enhancing early detection, treatment decisions, and patient management, making biomarkers central to cancer care advancements.
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
The veterinary lab automation market is projected to grow from $1.36 billion in 2026 to $1.9 billion by 2030, with a CAGR of 8.7%. Growth is fueled by rising demand for rapid diagnostics, AI integration, and precision veterinary medicine, alongside i...
The veterinary lab automation market is projected to grow from $1.36 billion in 2026 to $1.9 billion by 2030, with a CAGR of 8.7%. Growth is fueled by increasing demand for rapid diagnostics, AI integration, robotic workflows, and a focus on companio...
